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Background: Morbidity and mortality from cardiovascular diseases have decreased since
the 1970s in most Western societies. However, it is unclear if this positive trend can also be
found in younger women suffering from acute coronary syndrome (ACS).  
Methods: This is a prospective single center registry study including 11.015 women and
men hospitalized for a first ACS between the years 2001 and 2010. We analyzed ACS rates
according to sex and age group using Poisson regression in order to assess temporal
trends.
Results Overall ACS hospitalization rates per 100.000 inhabitants increased by 31%
between 2001 and 2010 (Rate Ratio (RR) of 1.31, 95% CI 1.20–1.43; p < 0.001) with a
similar increase in men (RR 1.29, p< 0.00001) and women (RR 1.35, p<0.0001).  Analyses
of age-specific ACS rates showed a significant increase in ACS hospitalization rates only
for the age groups 70-79 years (p = 0.003) and 80+ years (p < 0.00001). None of the age
matched subgroups showed a sex related significant difference in trend for ACS
hospitalization rates. Temporal trends for recorded risk factors showed a significant
increase in smoking (p=0.03), and a trend to increased obesity prevalence (p=0.06) in
females in the age group 60-69 years.
Conclusions: In contrast to other studies, we found no evidence for a particular increase in
the number of younger women referred for a first ACS during the years 2001 and 2010.
Potential negative effects of smoking and obesity on ACS incidence may be delayed to
women older than 70 years.
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Introduction
Cardiovascular diseases (CVD) and in particular coronary artery disease (CAD) remain the
leading cause of morbidity and mortality for both women and men in industrialized countries
1,2, such as in Switzerland.3 The incidence of acute coronary syndrome (ACS) is related to
risk factor levels in the population.4  Recent publications regarding ACS and CAD incidence
from USA and Europe show fluctuations in rates before 20005-10 followed by a decline during
the last decade11-14, except for Spain, for which  increased rates have been reported15. This
generally declining trend is considered to be due to better identification and control of
cardiovascular risk factors9,10, to improved drug regimens for CAD and to enhanced
myocardial revascularization strategies5,7-10. A majority of the studies state overall age-
standardized rates, while data on age-specific trends are rare. Taking age and sex into
account, increasing trends in ACS incidence have been reported among younger women
compared to younger men16-18. Potential explanations comprise non-favorable trends in
cardiovascular risk factors in adolescents and young adults and in non-atherosclerotic
causes of the disease in younger age groups19. While most Western countries show a
promising negative trend in smoking prevalence, overweight and type 2 diabetes are
generally increasing3,20-21.
The aim of this study is to investigate sex and age-specific trends in male and female
patients with ACS using data from a tertiary care center with stable referral area in
Switzerland taking into account age subgroups and to investigate underlying changes in





Over the time period of 2001-2010, the Cardiology Clinic of the University Hospital of Bern
(Inselspital Bern) was serving a referral area of about 1 million people and was the biggest
respective tertiary care center in Switzerland. During the study period, 53% of patients have
been referred for ACS from the canton Bern (BE), 18% from den canton Solothurn (SO),
approximately 10% from the canton Fribourg (FR) and the remaining from either canton
Ticino (TI) or canton Neuchâtel (NE).  Referral area remained stable throughout the
inclusion period, except for the canton NE replacing the canton TI. Until 2001,  canton TI
referred 5.3% of all patients and then ceased referral, whereas in the year 2001  canton NE
started to refer approximately the same proportion of patients. The number of competing
institutions has not changed during the study period: whereas an additional clinic started
offering coronary interventions in the year 2006, their influence on referral numbers was
offset by the fact, that in the same year a clinic with a comparable catchment area started
allocating their patients to the Bern University Hospital. Referrals from outside the
predefined area were minimal (≤ 20 per year). Demographic data on the referral cantons
was provided by the Swiss Federal Statistical Office  (BE, SO, FR and NE from 2001-2010).
Immigration to Switzerland increased from 124’077 in 2001 (63’139 men and 60’938
women) to 181’778 in 2010 (85’265 men and 96’513 women), with a majority from the age
group of 20-39 years and therefore low risk for ACS.
We included all patients with ACS undergoing coronary angiography and therefore fulfilling
eligibility criteria for an invasive procedure.  At our tertiary care center, coronary
angiography is performed in all ACS patients without absolute contraindications for invasive
procedures. University Hospital Bern has been using electronic data storage for all coronary
angiography reports since the early 1990s, including basic demographic data, and this
database was used for numerous publications over the last years22-24 . Diagnoses were
recorded as determined by the attending physicians based on clinical, electrocardiographic,
and biochemical (elevated troponin levels) criteria. Definitions of type of myocardial
infarction (ST-elevation vs non-ST-elevation) and unstable angina were homogeneous and
based on criteria according to current guidelines25. Only first ACS events were included and
 patients with a history of ACS, data of angiographies conducted on a second or later event
as well as all angiographies performed later than 2 weeks after initial diagnosis of ACS,
were excluded. Furthermore, presence and extend of coronary artery disease have been
recorded. For our study, a vessel was considered to be affected when a stenosis of ≥50%
was present, which led to the definition of one, two or three vessel disease.
Cardiovascular risk factors
Arterial hypertension, dyslipidemia and diabetes mellitus were recorded if stated in the
patient history or when the individual medication list at entry contained medication to control
these risk factors prior to the index hospitalization. Smoking status and family history for
CAD were also extracted from the patient history. Smoking was defined as current smoker
or smoking cessation within one year prior to the ACS. Obesity was defined as body mass
index >30 kg/m2.
Statistical analysis
For the statistical analyses, we grouped the patients according to age into 5 different age
groups: 20-49 years, 50-59 years, 60-69 years, 70-79 years and 80-99 years. We
calculated the annual number of first ACS by age groups for men and women, and, using
the demographic data of the catchment area, calculated rates of ACS hospitalization per
100.000 population of each specific sex and age group. To assess temporal trends of the
ACS hospitalization rates, we performed univariate and multivariate Poisson regression
analyses. For these, the total number of ACS hospitalizations was considered to be
Poisson distributed given the total population of the catchment area26. A p-value of ≤0.05





During the study period from 2001-2010, a total of 11.015 coronary angiographies were
performed in patients hospitalized with a first ACS (69.9% men). With very few exceptions,
patients have been Caucasian by race. Men were younger than women (62.3 ±12.3 vs.
69.2 ±11.5 years; p < 0.001). Over time, there was a significant increase in mean age at
ACS onset for both sexes. Mean male age increased from 61.7 in 2001 to 63.6 in 2010,
whereas mean female age increased from 67.8 in 2001 to 70.2 in 2010.
Overall ACS hospitalization rates per 100.000 inhabitants (Figure 1) increased by 31%
between 2001 and 2010 (Rate Ratio (RR) of 1.31, 95% CI 1.20–1.43; p < 0.001) with a
similar increase in men (RR 1.29, p< 0.00001) and women (RR 1.35, p<0.0001). No
statistical difference in trends for ACS hospitalization rates could be observed between the
sexes (p=0.254). Trends in ACS hospitalization rates over the study period were not
significantly different after age-adjusted analysis for males and females.
Analyses of age-specific ACS rates (Figure 2) showed a non-significant increase in ACS
hospitalization rates for the age groups 20-49 years (p = 0.4558), 50-59 years (p = 0.5110)
and 60-69 years (p = 0.6122). We found a significant increase in ACS hospitalization rates
for the age groups 70-79 years (p = 0.003) and 80+ years (p < 0.00001). Sex-specific
analyses showed that ACS hospitalizations increased in the 70-79 years old men and in the
80+ years male and female population. None of the age matched subgroups showed a sex
related significant difference in trend for ACS hospitalization rates.
Hospital mortality
Data on hospital mortality in ACS patients in our cardiology clinic are only available since
the year 2008 and was 5.6% in 2008, 5.1% in 2009 and 4.4% in 2010. However, this data
correspond well to data from the AMIS (Acute Myocardial Infarction in Switzerland)
Registry27 which included 21’620 STEMI-patients, 5786 women and 15’834 men from 78
Swiss hospitals over the time period between 1997 and 2011, where they found a decrease
of in-hospital mortality from 10 to 5% in men and from 18 to 7% in women during this time
period.
Cardiovascular risk factors
Temporal trends with regard to the risk factors obesity, diabetes and smoking are shown in
Figure 3 according to different age groups and displayed separately for men and woman.  
Obesity in ACS patients increased by 4% over the whole study period and was higher in
females (Relative Proportion of (RP) 1.21, 95%-CI: 1.10-1.34) compared to men. 80+ years
ACS patients were 37% less obese compared to the youngest age group (20-49 years).
This trend is not significantly different from overall trends in cardiovascular risk factors in




Severity of coronary artery disease
The number of affected vessels per patient (≥50% stenosis) remained stable in the younger
age groups, whereas the proportion of patients with one vessel disease decreased
significantly in the age groups 60-69 and 70-79 years (p=0.002), but without significant
differences between sexes.
Discussion
We found a significant overall increase of ACS referral rates to a tertiary care center in men
and women over the time period of 2001 to 2010 in an area of Northwestern Switzerland
with approximately 1 million inhabitants. However, the main driver for this increase was the
very elderly population. No significant differences in sex specific trends were observed. In
particular, we found no significant increase of referrals of younger women for ACS during
this time period.
Our findings are in contrast to several large studies28-30 reporting an increase in the
proportion of women presenting with ACS. However, others have shown a significant
decline in the proportion of women presenting with ACS over the past decade31. A potential
explanation for these discrepancies is a decrease in the rates of ST-elevation myocardial
infarction (STEMI) in both men and women, in accordance with global trends combined with
an increase in the diagnosis of non-ST-elevation myocardial infarction perhaps due to
corresponding changes in the definition of acute myocardial infarction during (AMI) the last
decade25 and to the increased use of sensitive troponin serum assays during this time
period.
Mean age of ACS onset increased significantly for both sexes. Women presenting with ACS
have consistently been shown to be older and to have more comorbidities when compared
with men.30-34 Furthermore, a registry study from Sweden reported an increase in the use of
PCI during index hospitalization in recent years in women with ST-elevation myocardial
infarction35. With regard to age group several studies have analyzed ACS hospitalization
rates among young adults18,36-38. Many prior studies reported increasing hospitalization
trends in a younger population and particularly in women. McManus et al.39 found an
increase in hospitalization rates of young individuals (<55 years) with STEMI during 1997–
2005. Another study found an increase in ACS hospitalization rates among women 20–49
years during 1994–200436. Similar increasing trends were reported by Towfighi et al.38 for
hospitalization rates among women 35–44 years during 1997–2006 and Nedkoff et
al.40found an annual increase of 4% in ACS incidence rates in women aged 35–54 years in
Western Australia during 1996–2007.  We cannot confirm an increase in hospitalization for
ACS patients less than 50 years of age among our study population. Only the increase in
the oldest age group (80+) was significant and can be explained by the increasing practice
of invasive procedures in the very elderly, parallel to the higher life expectancy. As shown in
a large Italian cohort study  consisting of 89.562 patients, the use of an invasive approach
increased markedly over time in both sexes (from 54.9% in 2000 to 91.9% in 2010 in men;
from 36.8% in 2000 to 72.0% in 2010 in women), while the change was mainly driven by
the subgroup of patients aged 75+ years41. Similar in Switzerland, where the procedure of
coronary angiography and PCI in ACS gained importance during the 1990s and rapidly
replaced systemic thrombolysis. Improved safety and feasibility of coronary interventions
during the past decade lead clinicians to include older and more fragile patients. In
particular, the underrepresentation of the very elderly and other vulnerable groups such as
renal patients42 in a majority of clinical trials underpins the importance to adequately
consider the changing age demographics and extension of established therapies to more
borderline populations.  
Over the recent years, most studies from the US and across Europe have shown
decreasing rates of ACS but differing trends in  ACS hospitalization11,43 . In Scandinavia and
in particular Norway and Sweden, ACS incidence rates declined during the first decade of
the 21st century, with a more pronounced decline in men than women44,45, and similar
tendencies have been reported from the Netherlands during 1998–200714,46 and the UK
during 2002-201047.
Compared to the general decrease in ACS for both sexes and across all age groups,
hospitalizations for ACS have a more ambiguous pattern with widely differing trends among
gender and age groups48. This overall decrease in ACS, in the face of partly stable or even
increasing hospitalizations for ACS most likely mirrors the advances in preventive care. In
particular, wide spread acceptance of evidence based preventive drug therapy leading to
decreased ACS morbidity, combined with increasingly sensitive cardiac biomarker assays,
continuous improvement in rapid response networks and ubiquitously implemented rapid
reperfusion facilities, is ultimately leading to increased hospitalization rates but decreased
mortality. However, because Switzerland has a highly developed health system with optimal
prevention and treatment facilities of ACS very different from many other countries49, the
data are not easily generalizable. And immigration seems not to have a significant impact
on hospitalization rates for ACS in our study cohort due to the relatively young age of most
immigrants and very low ACS risk in this age group.
During the study period, no significant differences have been observed in the
cardiovascular risk profile, except for the 60-69 years age group, in whom prevalence of
smoking and obesity increased slightly (Figure 3). The prevalence of hypertension,
hypercholesterinemia and smoking has substantially decreased in recent decades in most
populations. However, increasing prevalence of smoking (especially among young women),
obesity and physical inactivity in subgroups of adolescents and young adults have been
reported and may have contributed to unfavorable trends in ACS in several countries9,10.
This is supported by a high prevalence of these risk factors observed among young adults
hospitalized for their first AMI28. Within the WHO-MONICA study, it was estimated that
trends in major risk factors, such as systolic blood pressure, smoking and serum cholesterol
levels, explained 40% and 15% of the variability in coronary event rates in men and women,
respectively. Despite the lack of regional data on trends in risk factors in the investigated
referral area, national health surveys in Switzerland have shown an overall reduction in
hypertension, and serum cholesterol levels, similar to those reported from other countries.
However, - as an exception - smoking increased in younger women age 15-24 years,
whereas obesity and physical inactivity increased in all age groups.
 
Limitations
Our dataset does not represent the total number of ACS which occurred in the reference
area over time but rather hospitalization rates for ACS and therefore includes referral bias.
However, we assume that over the time period 2001-2010 indication for referral of ACS
cases to a tertiary care hospital did not change except for an expansion of indications for
interventional procedures in very elderly people in the age range  80+ years. Furthermore,
our data does not include information on ACS subtype, therefore we are not able to
examine whether the trends observed apply to different ACS subtypes. Our investigation is
restricted to hospitalized patients with ACS and angiography and does not include patients
hospitalized with ACS but with absolute contraindications for angiography and pre-hospital
ACS cases including out-of-hospital cardiac arrests. However, due to the large number of
patients included, it is unlikely that the inclusion of these cases would have significantly
influenced time trends over particular age groups and gender.
Strengths
Our study is the first to report gender specific trends in AMI incident hospitalization in a
representative and stable referral area in Northwestern Switzerland, using data from a
single tertiary care center registry. We included all individuals 20 years and older who were
hospitalized for ACS during 2001–2010, whereas most previous studies have been limited
in regard to the range of included age groups in particular by excluding the very elderly.
Serum troponin use  was adopted by the University Hospital of Bern during 1998–2000 and
therefore we expect minimal preconception due changing diagnostic criteria.
Conclusion
Whereas overall hospitalization for first incident  ACS in patients 20-100 years of age
increased in Switzerland during 2001–2010, the single driver of this increase was found to
be  the age group of the very elderly (80+), with no differences in gender and age specific
trends. This may be due to favorable trends with overall reduction of smoking, hypertension
and serum cholesterol levels in our population. However, a significant increase in smoking
prevalence and a trend towards increasing obesity in women in the age group 60-69 years
may indicate that a negative impact of these risk factors on ACS incidence may be delayed




1. ​Jørgensen T, Capewell S, Prescott E, et al. Population-level changes to promote
cardiovascular health. Europ J  Prev Cardiol 2013; 20: 409–421.
2. ​Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2013
update: a report from the American Heart Association. Circulation 2013; 127: e6–
e245.
3. ​http://www.bfs.admin.ch/bfs/portal/de/index/themen
4. ​Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors
associated with myocardial infarction in 52 countries (the INTERHEART study): case-
control study. Lancet 2004; 364: 937–952.
5. ​Beaglehole R. Medical management and the decline in mortality from coronary
heart disease. Br Med J (Clin Res Ed) 1986; 292: 33–35.
6. ​Rodríguez T, Malvezzi M, Chatenoud L, et al. Trends in mortality from coronary
heart and cerebrovascular diseases in the Americas: 1970-2000. Heart 2006; 92:
453–460.
7. ​Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from
coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388–2398.
8. ​Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease
mortality in England and Wales between 1981 and 2000. Circulation 2004; 109: 1101–
1107.
9. ​Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes
in mortality from ischaemic heart disease in Finland. British Medical J 1994; 309: 23–
27.
10. ​Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular
treatment and risk factor changes to the decline in coronary heart disease mortality in
Scotland between 1975 and 1994. Heart 1999; 81: 380–386.
11. ​Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and
outcomes of acute myocardial infarction. N Engl J Med 2010; 362: 2155–2165.
12. ​Chen J, Normand S-LT, Wang Y, et al. Recent declines in hospitalizations for
acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and
continuing challenges. Circulation 2010; 121: 1322–1328.
13. ​Fischer T, Lundbye-Christensen S, Johnsen SP, et al. Secular trends and
seasonality in first-time hospitalization for acute myocardial infarction--a Danish
population-based study. Internat J  Cardiol 2004; 97: 425–431.
14. ​Koopman C, Bots ML, van Oeffelen AAM, et al. Population trends and inequalities
in incidence and short-term outcome of acute myocardial infarction between 1998 and
2007. Internat J  Cardiol 2013; 168: 993–998.
15. ​Sans S, Puigdefábregas A, Paluzie G, et al. Increasing trends of acute
myocardial infarction in Spain: the MONICA-Catalonia Study. Eur Heart J 2005; 26:
505–515.
16. ​Lehto HR, Lehto S, Havulinna AS, et al. Are coronary event rates declining slower
in women than in men - evidence from two population-based myocardial infarction
registers in Finland? BMC Cardiovasc Disord 2007; 7: 35.
17. ​Lundblad D, Holmgren L, Jansson J-H, et al. Gender differences in trends of
acute myocardial infarction events: the Northern Sweden MONICA study 1985 - 2004.
BMC Cardiovasc Disord 2008; 8: 17.
18. ​Mannsverk J, Wilsgaard T, Njølstad I, et al. Age and gender differences in
incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The
Tromso Study. European Journal of Preventive Cardiology 2012; 19: 927–934.
19. ​Egred M, Viswanathan G, Davis GK. Myocardial infarction in young adults.
Postgrad Med J 2005; 81: 741–745.
20. ​Der Tabakkonsum der Schweizer Wohnbevölkerung in den Jahren 2001 bis 2010.
Jahresbericht BAG 2011; 1–78.
21. ​Marques-Vidal P, Bovet P, Paccaud F., Chiolero A. Changes of overweight and
obesity in the adult Swiss population according to education level from 1992-2007.
BMC Public Health 2010;10:87-92.
22. ​Giustino G, Baber U, Salianski O, et al. Safety and efficacy of New-Generation
Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in
Innovation and Drug-Eluting stents Collaborative Patient-Level Pooled Analysis.  Circ
Cardiovasc Interv 2016; 9(1): e00295
23. ​Pilgrim T, Piccolo R, Heg D, et al. Biodegradable polymer sirolimus-eluting stents
versus durable polymer everolimus-eluting stents for primary coronary
revascularisation of acute myocardial infarction. Eurointervention 2015;23;11(8):pii.
20150628.
24. ​Billinger M, Räber L, Hitz S, et al.  Long-term clinical and angiographic outcomes
of diabetic patients after revascularization with early generation drug-eluting stents.
Am Heart J 2012; 163(5):876-886.
25. ​Thygesen K, Alpert JS and White HD on behalf of the Joint
ESC/ACCF/AHA/WHF task Force for the Redefinition of Myocardial Infarction.
Universal definition of myocardial infarction. Europ Heart J 2007;28 (20):2525-2538.
 
26. ​Kirkwood BR, Sterne JAC. Poisson regression. In: Essential Medical Statistics:
Oxford Blackwell Science Ltd 2003: 249-256.
27.   Radovanovic D, Nallamothu B, Seifert B, et al. Temporal trends in the treatment of ST-
elevation myocardial infarction among men and women in Switzerland between 1997
and 2011. Europ Heart J Acute Cardiovascular Care 2012;1(3):183-191.
28. ​Rogers WJ, Frederick PD, Stoehr E, et al. Trends in presenting characteristics
and hospital mortality among patients with ST elevation and non-ST elevation
myocardial infarction in the National Registry of Myocardial Infarction from 1990 to
2006. American Heart J 2008; 156: 1026–1034.
29. ​Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and
outcomes of acute myocardial infarction. N Engl J Med 2010; 362: 2155–2165.
30. ​Hvelplund A, Galatius S, Madsen M, et al. Women with acute coronary syndrome
are less invasively examined and subsequently less treated than men. Eur Heart J
2010; 31: 684–690.
31. ​Sabbag A, Matetzky S, Gottlieb S, et al. Recent Temporal Trends in the
Presentation, Management, and Outcome of Women Hospitalized with Acute
Coronary Syndromes. Am J Medicine 2015; 128: 380–388.
32. ​Milcent C, Dormont B, Durand-Zaleski I, et al. Gender Differences in Hospital
Mortality and Use of Percutaneous Coronary Intervention in Acute Myocardial
Infarction: Microsimulation Analysis of the 1999 Nationwide French Hospitals
Database. Circulation 2007; 115: 833–839.
33. ​Nauta ST, Deckers JW, van Domburg RT, et al. Sex-Related Trends in Mortality in
Hospitalized Men and Women After Myocardial Infarction Between 1985 and 2008:
Equal Benefit for Women and Men. Circulation 2012; 126: 2184–2189.
34. ​Kaul P, Armstrong PW, Sookran S, et al. Temporal trends in patient and treatment
delay among men and women presenting with ST-elevation myocardial infarction.
American Heart J 2011; 161: 91–97.
35. ​Lawesson SS, Alfredsson J, Fredrikson M, et al. Time trends in STEMI--improved
treatment and outcome but still a gender gap: a prospective observational cohort
study from the SWEDEHEART register. British Med J Open 2012; 2: e000726–
e000726.
36. ​Fang J, Alderman MH, Keenan NL, et al. Acute Myocardial Infarction
Hospitalization in the United States, 1979 to 2005. Am J Med 2010; 123: 259–266.
37. ​Tu JV, Nardi L, Fang J, et al. National trends in rates of death and hospital
admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004.
CMAJ 2009; 180: E118–E125.
38. ​Towfighi A, Markovic D, Ovbiagele B. National Gender-Specific Trends in
Myocardial Infarction Hospitalization Rates Among Patients Aged 35 to 64 Years.
American J of Cardiol 2011; 108: 1102–1107.
39. ​McManus DD, Piacentine SM, Lessard D, et al. Thirty-Year (1975 to 2005) Trends
in the Incidence Rates, Clinical Features, Treatment Practices, and Short-Term
Outcomes of Patients <55 Years of Age Hospitalized With an Initial Acute Myocardial
Infarction. American J of Cardiol 2011; 108: 477–482.
40. ​Nedkoff LJ, Briffa TG, Preen DB, et al. Age- and Sex-Specific Trends in the
Incidence of Hospitalized Acute Coronary Syndromes in Western Australia.
Circulation: Cardiovasc Qual and Outcomes 2011; 4: 557–564.
41. ​Corrada E, Ferrante G, Presbitero P, et al. Eleven-Year Trends in Gender
Differences of Treatments and Mortality in ST-Elevation Acute Myocardial Infarction in
Northern Italy, 2000 to 2010. American J of Cardiol 2014; 114: 336–341.
42. ​Coca SG, Krumholz HM, Garg AX, et al. Underrepresentation of renal disease in
randomized controlled trials of cardiovascular disease. JAMA 2006; 296: 1377–1384.
43. ​Floyd KC, Yarzebski J, Spencer FA, et al. A 30-Year Perspective (1975-2005) Into
the Changing Landscape of Patients Hospitalized With Initial Acute Myocardial Infarction:
Worcester Heart Attack Study. Circulation: Cardiovascular Quality and Outcomes 2009; 2:
88–95.
44. ​Sulo G, Igland J, Nygard O, et al. Favourable trends in incidence of AMI in
Norway during 2001-2009 do not include younger adults: a CVDNOR project. Europe
J Prev Cardiol 2014; 21: 1358–1364.
45. ​Yang D, Dzayee DAM, Beiki O, et al. Incidence and case fatality after day 28 of
first time myocardial infarction in Sweden 1987-2008. European Journal of
Cardiovascular Prevention & Rehabilitation 2011; 19: 1741826711425340–1315.
46. ​van Oeffelen A, Agyemang C, Koopman C, et al. Downward trends in acute
myocardial infarction incidence: how do migrants fare with the majority population?
Results from a nationwide study. European Journal of Preventive Cardiology 2014; 21:
1493–1500.
47. ​Smolina K, Wright FL, Rayner M, et al. Determinants of the decline in mortality
from acute myocardial infarction in England between 2002 and 2010: linked national
database study. British Med J 2012; 344: d8059–d8059.
48. ​Gupta A, Wang Y, Spertus JA, et al. Trends in Acute Myocardial Infarction in
Young Patients and Differences by Sex and Race, 2001 to 2010. JACC 2014; 64:
337–345.
49.    Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe:












Figure 1: ACS rates (events/100’000 inhabitants) in men and women from 2001 to 2010
 
Figure 2: ACS hospitalization rates of men and women according to age groups from 2001
to 2010
 
Figure 3: Percentage of ACS patients presented with the risk factors obesity, diabetes or
smoking from 2001 to 2010 (top: men; bottom: woman; left: 20-49 years; middle: 50-59
years; right: 60-69 years)
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